GSTA1 and metabolic dysfunction-associated steatotic liver disease: The expression of GSTA1 was decreased in mouse models of MASLD induced by HFD-feeding [40], in mouse and patient livers [41], and in HepG2 cells treated with proinflammatory cytokines [42].